Given that 2 had increased narcotic use, and 9 decreased including 6 who dropped it entirely, the question remains whether you consider the data sufficiently objective.
Well. I wouldn't. Narcotic usage is driven by pain perception and perhaps even the results of the bone scan itself. And pain is notoriously subjective. I doubt that jq denies all benefit, and certainly I don't - but the bone scan data is, at best, interesting IMO.
PS I agree with jq regarding the fact that with the bone scan data being so dramatic you'd expect that if it was fully representative of disease state that the pain reduction would be greater.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.